We describe a high-resolution melting (HRM) analysis method that is rapid, reproducible, and able to identify reference strains and further 40 clinical isolates of Aspergillus fumigatus (14), A. lentulus (3), A. terreus (7), A. flavus (8), A. niger (2), A. welwitschiae (4), and A. tubingensis (2). Asp1 and Asp2 primer sets were designed to amplify partial sequences of the Aspergillus benA (beta-tubulin) genes in a closed-, single-tube system. Human placenta DNA, further Aspergillus (3), Candida (9), Fusarium (6), and Scedosporium (2) nucleic acids from type strains and clinical isolates were also included in this study to evaluate cross reactivity with other relevant pathogens causing invasive fungal infections. The barcoding capacity of this method proved to be 100% providing distinctive binomial scores; 14, 34, 36, 35, 25 , 15, 26 when tested among species, while the within-species distinction capacity of the assay proved to be 0% based on the aligned thermodynamic profiles of the Asp1, Asp2 melting clusters allowing accurate species delimitation of all tested clinical isolates. The identification limit of this HRM assay was also estimated on Aspergillus reference gDNA panels where it proved to be 10-10 2 genomic equivalents (GE) except the A. fumigatus panel where it was 10 3 only. Furthermore, misidentification was not detected with human genomic DNA or with Candida, Fusarium, and Scedosporium strains. Our DNA barcoding assay introduced here provides results within a few hours, and it may possess further diagnostic utility when analyzing standard cultures supporting adequate therapeutic decisions.
Introduction
Invasive fungal infections (IFI) are associated with high lethality rates representing a serious health problem in immunocompromised patients. Aspergilli are among the most significant fungal etiological agents of life-threatening invasive infections especially in patients with neutropenia, hematologic malignancies (acute leukemia) and in patients undergoing hematopoietic stem cell transplantation. 1, 2 Even with underestimated, poor epidemiological data the burden of invasive aspergillosis (IA) is on the rise. 3 This expansion is due to improved antimicrobial therapies and supportive care raising the number of severely immunocompromised patients thus putting them at higher risk of acquiring opportunistic fungal infections. 4 Aspergillus fumigatus is the prominent agent of IA 5 ;
however, several other species have also been reported from various clinical samples, such as A. terreus, A. flavus and A. niger. [6] [7] [8] [9] [10] [11] [12] Recently, IA cases due to rare Aspergilli such as A. lentulus have also been reported having low in vitro susceptibilities to a wide range of antifungals including amphotericin B, azoles, echinocandins. 13, 14 In clinical settings misidentification of A. lentulus with A. fumigatus has been increasingly reported by clinical laboratories. 15 Infections due to A. terreus are also difficult to treat because of their refractoriness to certain antifungal drugs, often causing disseminated infections with increased lethality. 16 The correct and prompt identification of Aspergillus species is of high importance because knowledge of species identity may influence adequate antifungal therapy given that different species have variable susceptibilities to multiple antifungal drugs. [17] [18] [19] [20] Mortality among intensive care unit (ICU) patients with IA can be as high as 90% but the overall mortality rate for IA is about 50% if diagnosed timely and treated. 21, 22 Accurate diagnosis of IA raises challenges to clinical microbiology laboratories. Clinical signs and symptoms are non-specific and standard culture-based diagnostics are typically too insensitive or nonspecific. 23 Identification of unknown Aspergillus clinical isolates to species is a polyphasic approach including morphotyping, growth temperature regimes, investigation of drug susceptibility patterns, and molecular characterization. 24 Furthermore, clinical isolates are not necessarily morphologically uniform representing aberrant conidiophore formation, therefore mistaken identification of species by morphological characteristics have occurred in the past. 14 Since culture techniques typically require specialized expertise for recovery and species determination, many laboratories can rely only on DNA based methodologies. 25, 26 Surrogate-marker based molecular assays can provide better prognostic data. In routine clinical settings, the detection of Aspergillus galactomannan (GM) is based on labor intensive, well standardized Platelia-Aspergillus enzyme immunoassay (EIA), which is considered to be the gold-standard possessing numerous attractive features. Nevertheless, as GM is a panfungal marker it is not suitable for the identification of Aspergilli to the species level. [27] [28] [29] There is a dire need for the development of newer diagnostic techniques to identify causative agents to species rapidly, noninvasively, and at an early stage of the disease.
Molecular techniques in addition to morphological identification have been shown to offer high resolution of species within the genus.
14 Recent, multiple studies prove that polymerase chain reaction (PCR)-based techniques appear to be promising in terms of speed, economy, and resolution power with available methodological recommendations to facilitate both manual and automated nucleic extraction technology. [30] [31] [32] [33] [34] Molecular barcoding relies on short, conserved genetic markers in the genome permitting the specific identification of the different species. [35] [36] [37] Recently, fast, high throughput post-PCR due to high-resolution melting analysis has been developed and effectively used for this reason. 38 High resolution melting (HRM) analysis is able to determine accurately the relationship between temperature and the extent of denaturation of DNA in the presence of saturating, double stranded DNA intercalating dyes. 39 The denaturation of the different DNA fragments with increasing temperature defines the characteristic melting domains and the shape of the derivative melting curves represents the taxonomic signatures of the here-tested species. This paper describes the development of an HRM based molecular barcoding assay tailored to prompt, accurate identification to the species level of clinically relevant Aspergillus isolates. Our sequence typing method targets two different regions of Aspergillus benA genes for the specific identification and discrimination of different clinical isolates of Aspergilli to the species level. Due to the fact that this HRM technique generates duplex, distinct peaks in case of different Aspergillus species, our method introduced here has a high resolving power with a short turnaround time reducing the risk of contamination and saving expenses. These features make our method advantageous for use as a first-pass diagnostic adjunct in microbiology laboratories.
Materials and methods

Collection and identification of fungal strains used in this study
Genomic DNA samples of clinically relevant Aspergillus, Candida, Fusarium, and Scedosporium strains were examined. The reference strains and the clinical isolates (Table 1) were maintained at the Department of Microbiology, University of Szeged on Sabouraud-chloramphenicol Table 1 . List of the reference and clinical strains examined by Asp1-Asp2 duplex HRM assay. slant agar and periodically subcultured. The species level identifications of the different clinical isolates were carried out by conventional morphological methods and the results were confirmed by sequence analysis of part of the calmodulin (Aspergilli), ribosomal RNA (Candida and Scedosporium species), and TEF1-alpha (Fusaria) genes.
DNA extraction
All fungal DNA extraction steps were performed in a class II laminar-flow cabinet to avoid environmental contamination.
r Aspergillus reference strains and clinical isolates were cultivated on standard minimal nitrate medium. 40 Aspergillus genomic DNA extraction was carried out at the University of Debrecen and at the University of Szeged. DNA was isolated from liquid cultures grown in minimal medium at 37 Asp1-Asp2 HRM assay design
Annotated Aspergillus benA genes were extracted from public databases to make multiple alignments using Clustal Omega. When designing primers, three main criteria were considered: (i) the amplicon length beyond 200 bp was considered to be maleficent, (ii) the length of forward and reverse primers should be beyond 18 bp to enhance specificity and proper hybridization to the target regions, (iii) amplicons should cover enough mismatches to enable proper discrimination among the tested strains.
Verification of the amplicons
Before applying the Asp1 and Asp2 primer sets ( Fig. 1 Genetic Analyzer instrument (Applied Biosystems) in both directions using the Asp1 and Asp2 forward and reverse primers. Figure 1 shows the thermal stability of the Asp1 and Asp2 amplicons along with their guanine and cytosine (GC) content and melting temperatures (T m ). Sequencing data were then analyzed comparing to the databases (http://blast.ncbi.nlm.nih.gov/BLAST.cgi) to clarify any discrepancy.
Setting the optimal HRM-real time PCR conditions
In order to monitor the accumulation of the amplified products through real-time PCR reactions, to determine characteristic melting-curve profiles and the representative melting temperatures (T m ) of the different strains, the real-time 
Taxonomy footprints
To typify the fungal footprints of the Asp1-Asp2 HRM assay on the major, clinically relevant Aspergilli the primers were used with the genomic DNA samples of the A. Table 1 . Approximately 20 ng of genomic DNA was used for every PCR reaction. To determine the differences in thermal stability of the resulting amplicons and representing the characteristic duplex T m peaks (LightCycler R 96 HRM analysis Software, Roche Diagnostics) and the descriptive melting curve profiles of the different strains samples were analyzed in duplicates.
Limit of detection
For measuring the analytical sensitivity of the Asp1-Asp2 HRM assay we artificially contaminated (spiked) PCR grade water samples with fungal gDNA, and we made seven reference panels (A. . Serial dilution was made in a 5 log range with 30 ng, 3 ng, 300 pg, 30 pg, 3 pg fungal gDNA in 6.6 μl nuclease free water (S1). Triplicate PCR reactions were performed. Threshold cycle (Cq) data were estimated. The correlation between Cq and genomic load was determined by linear regression plotting Cq values against the log of genome number. Standard curves were built where the linear ranges of these plots determined the linear dynamic ranges. Efficiency was calculated according to the following formula, E = (10 − 1 / slope). Efficiency was converted to percentage efficiency by using the formula, E% = (E − 1) × 100. 42, 43 Limit of reliable identification For measuring the limit of reliable identification of the Asp1-Asp2 HRM assay we estimated the lowest template DNA concentration by which the joint appearance of the Asp1 and Asp2 melting domains are still observable. We also compared the overlaying melting peaks of the melting domains of the different Aspergillus reference panels to test the different template DNA concentrations (30 ng -300 fg) providing reliable HRM patterns.
Cross reactions and discriminatory power r Possible cross reactions of the Asp1-Asp2 HRM assay were tested with approximately 5-25 ng human genomic DNA samples of human placenta (Sigma Aldrich, Missouri, USA) and with gDNA samples of two Candida type strains (Candida albicans ATCC 10231, C. parapsilosis ATCC 22019), further seven Candida (ID44-50), three Aspergillus (ID41-43), six Fusarium (ID51-53), two Scedosporium (ID57-58) isolates (Table 1) . In-house quality assessment of Asp1-Asp2 duplex HRM assay
The aim was to estimate the precision of the Asp1-Asp2 HRM assay and to confirm that results generated are consistent over time.
r Determining the repeatability. To estimate the intraassay consistency of the Asp1-Asp2 HRM assay coefficient of variation (% C.V.) was calculated for Asp1-T m and Asp2-T m triplicate melting temperatures in case of every sample of the six different Aspergillus reference gDNA panels and on the A. welwitsciae ID35 clinical gDNA panel. For this, standard deviation (±SD) of triplicates was taken, dividing that numbers by the means of the triplicate values and multiplying them by 100 (S1). Finally, the grand mean of the sample coefficient of variations (average % C.V.-s) of the triplicates was taken. In case the intra-assay % C.V. is less than 10% the method has high precision.
r Determining the reproducibility. Inter-assay consistency (plate-to-plate variation) of the Asp1-Asp2 duplex HRM assay was estimated between the three Aspergillus clinical panels containing the DNA samples of 40 different Aspergillus clinical strains. Duplicate PCR reactions were performed on every sample on three different days (plate 1, plate 2, plate 3). Asp1-T m and Asp2-T m means were calculated (S2). Plate T m duplicate means of adherent clinical strains of the different species were assembled and overall mean was calculated. Plate coefficient of variations (% C.V.) was calculated (Table 2) . Finally, grand mean of the sample coefficient of variations (average % C.V.-s) was taken. Inter-assay % C.V. values less than 15% are generally acceptable.
Results
In silico assessment of the discriminatory capacity
Using the DNA sequence data of the GENE database of the National Center for Biotechnology Information (http://www.ncbi.nlm.nih.gov/gene) we designed primers based on Aspergillus benA sequences (Fig. 1a) . • C).
The mean melting temperature (T m ) values of the resulted amplicons proved to be 82.27
• C ± 1.91, suggesting that the Asp1-Asp2 HRM assay shows sufficient diversity among clinically relevant Aspergillus species allowing their identification (Fig. 1b) .
Optimal reaction conditions
Optimal reaction conditions were determined as described in the materials section. 0.2 μM primer concentration, 3 mM MgCl 2 and annealing at 62
• C proved to be optimal. Figure 2a . The melting curves were normalized to eliminate differences in background fluorescence and are shown in the form of a temperature-shifted curve along the temperature axis (Fig. 2b) . Table 2 . Calculating inter-assay coefficient of variation of the Asp1-Asp2 duplex HRM assay.
Footprints of the assay on different species
Note: Asp1-T m and Asp2-T m duplicate means of adherent clinical strains of the different species were assembled in case of every plate and overall mean was calculated. Plate coefficient of variation was calculated for the different species. Finally, grand mean of the sample coefficient of variations (average % C.V.-s) was calculated.
Limit of detection and the limit of reliable identification
The detection limit of the Asp1-Asp2 HRM assay was determined on seven Aspergillus gDNA panels (S1) containing serially diluted genomic DNA samples in a 5-log range (30 ng to 3 pg). In each case, triplicate PCR reactions were performed to subtract threshold cycle (Cq) values and to analyze overlaying Asp1 and Asp2 melting peaks of the different samples. To study the correlation between the Cq-s of the qPCR and the genomic load standard curves were obtained by plotting Cq values against the log of genome number (GE). Linear dynamic ranges (Fig. 3a) , PCR efficiency (E) and correlation coefficient (R 2 ) were also estimated using the standard curve data (Fig. 3b) of the different Aspergillus panels. Along with measuring the analytical sensitivity we also estimated the lowest concentration of template DNA where reliable identification was attainable with our assay on these gDNA panels. The lowest amount of the template DNA where reliable HRM curves were obtainable with conclusive double peaks of the Asp1 and Asp2 melting domains proved to be 3 pg (10 2 GE) on all gDNA panels (Figure 4b, 4g ) but the A. fumigatus Af293 and the A. tubingensis CBS 134.48 gDNA panels (Fig. 4a) . In the case of the A. fumigatus Af293 panel the Asp1-Asp2 duplex HRM assay provided unreliable melting curves in the presence of 3 pg gDNA representing only a single, inconclusive melting domain of this sample (Fig. 4a) . When testing A. tubingensis CBS 134.48 gDNA panel, the reliable LoD proved to be 300 fg (10 GE) (Fig. 4g) .
Assay cross reactivity
The cross-reactivity of the Asp1-Asp2 HRM assay was examined with human genomic DNA ( Figure 5 ). (Table 3) . 26) sharing one clusters in common and adjacent clusters we also suggest considering the peak distances as an adjunct parameter when barcoding the species (Fig. 6a) . Species specific Asp1 and Asp2 peak T m values were used for measuring the median of the T m difference data (Fig. 6b-6c Asp1-Asp2 HRM assay passed the in-house quality assessment
To assess the repeatability of the Asp1-Asp2 HRM assay we applied on the six Aspergillus reference panels (A. For measuring the precision of the assay average coefficient of variation was calculated for the triplicate Asp1 and Asp2 mean T m values where intraassay % C. V. proved to be 0.09% accounting for a very high accuracy of the assay (S1). Plate-to-plate consistency was also assessed for the assay on three Aspergillus clinical panels (panel 1, 2, 3) on three different days composing of 5-15 ng genomic DNA of the 40 different clinical isolates (S2). Inter-run precision (reproducibility) was measured between three Aspergillus clinical panels and sample coefficient of variations (average % C.V.-s) between the three plates were taken, where inter-assay % C.V proved to be 2.44% (Table 2) , which is highly acceptable.
Discussion
Aspergillosis is the most common invasive mold disease worldwide, 5 and to data, there is a growing number of various molecular methods to identify biological samples contaminated with traces of Aspergillus conidia or DNA. 23, 26, 27, [30] [31] [32] [33] [34] Rapid and noninvasive molecular barcoding methods for detecting and identifying pathogens directly from clinical samples are under the spotlight [35] [36] [37] [38] [39] since most cultured specimens have only a single dominant causative agent; 44, 45 furthermore, the number of clinically relevant Aspergillus species may also be limited. 46 Recent data also support that applications resting on high resolution melting analyses may be ideally suited for barcoding of fungal pathogens. [44] [45] [46] [47] [48] [49] Species level identification of the Aspergillus species may be important especially in case of the cryptic species because some of these strains are associated with special growth Table 3 . Representation of the six melting peak cluster (cluster 1-cluster 6) T m ranges of the Asp1 and Asp2 melting domains.
Note: Representation of the six melting peak cluster (cluster 1-cluster 6) T m ranges of the Asp1 and Asp2 melting domains with the mean melting temperatures and standard deviations (±SD) assigned to the different clinical strains on completion of the analyses of the three Aspergillus clinical panels. Binomial scores were generated in case of the different strains tested according to their Asp1 and Asp2 melting clusters (cluster 1; score 1, cluster 2; score 2, cluster 3; score 3, cluster 4; score 4, cluster 5; score 5, cluster 6; score 6) unequivocally defining the different species according to their binomial scores; (14) features and antifungal resistance. 14, 43, [50] [51] [52] [53] Reliable, species level detection of the typically moderately-growing fungi from cultured specimens may take several days 34 delaying adequate diagnosis and setting back the timely initiation of appropriate antifungal treatment. Prompt, correct, species level identification of pathogen fungi furthermore requires nucleic acid based techniques. [30] [31] [32] [33] [34] Although HRM based methods do not have the resolving power as the sequencing or are not as sensitive as the TaqMan probe based systems, they became more and more attractive to molecular diagnostic laboratories. 35, 39 Multiple studies have demonstrated the limited utility and enhanced major drawbacks of morphotyping used alone for species identification of clinically relevant Aspergilli recognizing that DNA based applications used in tandem with morphological examinations can offer better resolution of species within the genus. 14 The prime aim of this study was to describe a method that may be promising especially to traditional culturing techniques in virtue of identifying numerous clinical isolates of relevant Aspergilli to species with very high accuracy. Our Asp1-Asp2 HRM method introduced here uses two primer sets (Asp1 and Asp2) targeting two differently conserved regions (Asp1 and Asp2 melting domains) of the Aspergillus benA genes. On the basis of the thermodynamic characteristics of the amplicons and the joint appearance of the melting peaks of the Asp1 and Asp2 melting domains and their T m peak distances, our assay was shown to have higher resolution power displaying deviations among species than other single locus based HRM systems. This enables us to identify the gDNAs derived from 40 48 ) were sequenced; then the sequences were aligned surveying potential sequence deviations within species. Based on our data we presumed that our Asp1 and Asp2 amplicons will display enough sequence divergence between closely related species but at the same time may be conserved enough targeting the different clinical isolates within species.
In the work presented here the gDNA of six Aspergillus reference and further 40 clinical isolates were used as a proof of concept. Furthermore, our Asp1-Asp2 duplex HRM assay was tested and optimized experimentally on human gDNA and on relevant Candida, Fusarium, Scedosporium strains (Table 1) . Neither the human gDNA, nor the clinical isolates resulted misidentification with our assay. We also proved that even the presence of excess human gDNA did not affect assay results.
Molecular barcoding of the different strains was conducted by real-time PCR amplification; then species discrimination was performed by analyzing of the characteristic thermodynamic profiles using generic double-stranded DNA binding fluorescent dyes. When testing DNA samples of the numerous Aspergillus clinical strains (ID1-40) they displayed conclusive, species specific double melting peaks in the presence of 5-15 ng Aspergillus gDNA. Conversely, the peaks of the Asp1 and Asp2 domains of the examined Aspergilli were then assigned to the respective melting clusters. Binomial scores given to the strains unequivocally identified all the 40 examined Aspergilli (Table 3) ; thus, the species barcoding accuracy of the method proved to be 100%. The analytical sensitivity of this assay was also measured and proved to be 10 2 or lower GE on all reference panels but the A. fumigatus panel. This information may be necessary when testing different liquid tissue samples that yield low copy numbers of fungal DNA, which is often the case when fungal gDNA is extracted from bronchoalveolar lavage (BAL), whole blood, serum, or plasma samples. We also estimated the identification limit of the Asp1-Asp2 HRM assay by analyzing the overlaying melting peaks of the different melting clusters. From the observed cluster patterns, we concluded that our HRM assay is specific, provides highly reproducible thermodynamic characteristics (Fig. 4) , and could detect the subtle sequence differences of the Asp1 and Asp2 melting domains preferentially when extracting gDNA from young fungal cultures followed bead beating of the hyphae and conidia. In-house assay performance measurements were also conducted confirming the high accuracy and reproducibility of the Asp1-Asp2 assay. We also confirmed that Asp1 and Asp2 HRM assay results may be consistent over time using the same PCR-HRM platform.
Our prime purpose was to introduce a simple, robust, and highly reproducible molecular barcoding tool that relies on HRM analysis. This article describes a rapid, practical and precise DNA typing method with a high resolution power for the molecular identification of relevant Aspergillus clinical isolates to the species level. We believe that this method should be also applied in other research or diagnostic laboratories when more strains were available to test further relevant Aspergillus clinical isolates and to prove its applicability or to reveal possible drawbacks. Asp1-Asp2 may be capable to distinguish all clinically relevant strains of the above tested Aspergilli even at limiting initial template concentrations so the diagnostic power of our method should be further investigated on liquid tissue specimens. Nevertheless, just like other HRM based applications our molecular barcoding method introduced here possesses inherent simplicity so may be amenable for automatization. We hope that our method will help to identify and discriminate causative agents of aspergillosis more promptly and accurately giving more insight into the pathogenesis and treatment of infection.
